Rwanda vs United Kingdom of Great Britain and Northern Ireland: Access to anti-retroviral drugs, male

Rwanda
95.0%
in 2024
United Kingdom of Great Britain and Northern Ireland
93.0%
in 2023
Rwanda rank
4th
United Kingdom of Great Britain and Northern Ireland rank
7th

Access to anti-retroviral drugs, male over time

  • Rwanda
  • United Kingdom of Great Britain and Northern Ireland
020406080100200020122024

How they compare

Rwanda currently reports 95.0% against 93.0% in United Kingdom of Great Britain and Northern Ireland, a difference of 2.0%.

The two have swapped places 1 time across 8 shared years of data; in 2016 it was United Kingdom of Great Britain and Northern Ireland ahead.

Rwanda ranks 4th and United Kingdom of Great Britain and Northern Ireland ranks 7th of 141 countries.

United Kingdom of Great Britain and Northern Ireland has averaged higher in every one of the 2 decades both report.

Head to head by decade

Decade Rwanda United Kingdom of Great Britain and Northern Ireland Difference Ahead
2010s 76.0% 92.0% 16.0% United Kingdom of Great Britain and Northern Ireland
2020s 88.8% 93.2% 4.5% United Kingdom of Great Britain and Northern Ireland

Averages of every year both report within each decade.

Frequently asked questions

Which has higher access to anti-retroviral drugs, male, Rwanda or United Kingdom of Great Britain and Northern Ireland?
Rwanda, at 95.0% against 93.0% in United Kingdom of Great Britain and Northern Ireland as of 2024.
What is the difference in access to anti-retroviral drugs, male between Rwanda and United Kingdom of Great Britain and Northern Ireland?
2.0%, with Rwanda ahead.
How many years of comparable data are there for Rwanda and United Kingdom of Great Britain and Northern Ireland?
8 years are reported by both, from 2016 to 2023.
How do Rwanda and United Kingdom of Great Britain and Northern Ireland rank globally for access to anti-retroviral drugs, male?
Rwanda ranks 4th and United Kingdom of Great Britain and Northern Ireland ranks 7th of 141 countries.
Where does this data come from?
UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Rwanda vs United Kingdom of Great Britain and Northern Ireland: Access to anti-retroviral drugs, male. Statizoid, drawing on UNAIDS estimates. Retrieved 16 September 2026, from https://gender.statizoid.com/compare/access-to-anti-retroviral-drugs-male-percent/rwanda/united-kingdom/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://gender.statizoid.com/compare/access-to-anti-retroviral-drugs-male-percent/rwanda/united-kingdom/">Rwanda vs United Kingdom of Great Britain and Northern Ireland: Access to anti-retroviral drugs, male</a> — Statizoid

About this data

Indicator
Access to anti-retroviral drugs, male (%)
Unit
%
Source
UNAIDS estimates
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
160 places, 3,923 data points, 2000–2024
Last refreshed

The percentage of adult males living with HIV who are receiving antiretroviral therapy.